Showing results (91-100 of 209) with videos related to
Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2020
Synthetic High-density Lipoprotein Nanodiscs for Personalized Immunotherapy Against GliomasLindsay Scheetz, Padma Kadiyala, Xiaoqi Sun, et al.Oncotarget|November 19, 2016
CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown studyViveka Nand Yadav, Daniel Zamler, Gregory J Baker, et al.Journal of Neurosurgery|September 25, 2007
Improved distribution of small molecules and viral vectors in the murine brain using a hollow fiber catheterSeunguk Oh, Rick Odland, Scott R Wilson, et al.Expert Opinion on Therapeutic Targets|June 12, 2018
Mutant ATRX: uncovering a new therapeutic target for gliomaSantiago Haase, María Belén Garcia-Fabiani, Stephen Carney, et al.Expert Opinion on Biological Therapy|July 14, 2016
Recent advances and future of immunotherapy for glioblastomaNeha Kamran, Alexandra Calinescu, Marianela Candolfi, et al.Molecular Therapy. Methods & Clinical Development|July 29, 2014
Marmosets as a preclinical model for testing "off-label" use of doxycycline to turn on Flt3L expression from high-capacity adenovirus vectorsNathan VanderVeen, Christopher Paran, Ashley Appelhans, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene TherapyNeha Kamran, Padma Kadiyala, Meghna Saxena, et al.Plos One|August 21, 2008
T cells' immunological synapses induce polarization of brain astrocytes in vivo and in vitro: a novel astrocyte response mechanism to cellular injuryCarlos Barcia, Nicholas S R Sanderson, Robert J Barrett, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejectionCécile Guillot, Carole Guillonneau, Patrick Mathieu, et al.JAMA Neurology|July 13, 2026
Recent Advances and Future Prospects in Gene Delivery Platforms for Glioblastoma: A ReviewAlexander F Haddad, Rithvik Ramesh, Jorge Armando Peña Agudelo, et al.Pageof 21